Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Elvidge

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|December 6, 2021
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over TimeGemma E Shields, Becky Pennington, Ash Bullement, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2016
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in SwedenSixten Borg, Hareth Nahi, Markus Hansson, et al.
International Journal of Technology Assessment in Health Care|July 23, 2019
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic ReviewGemma Elizabeth Shields, Deborah Buck, Jamie Elvidge, et al.
International Journal of Technology Assessment in Health Care|April 24, 2023
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendationsJamie Elvidge, Ashley Summerfield, Saskia Knies, et al.
Journal of Affective Disorders|February 18, 2019
Risk assessment scales to predict risk of hospital treated repeat self-harm: A cost-effectiveness modelling analysisLeah Quinlivan, Sarah Steeg, Jamie Elvidge, et al.
Frontiers in Pharmacology|January 29, 2024
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshopRavinder Claire, Jamie Elvidge, Shahid Hanif, et al.
Pharmacoeconomics|January 18, 2023
Living Health Technology Assessment: Issues, Challenges and OpportunitiesPraveen Thokala, Tushar Srivastava, Robert Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in EuropeTuba Saygın Avşar, Jamie Elvidge, Claire Hawksworth, et al.
International Journal of Technology Assessment in Health Care|January 28, 2026
Innovating HTA: a call for capacity building and standardizationDiana M J Delnoij, Dalia M Dawoud, Jamie Elvidge, et al.
Journal of Comparative Effectiveness Research|June 21, 2022
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriersMaria Kamusheva, Bertalan Németh, Antal Zemplényi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|December 6, 2021
Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over TimeGemma E Shields, Becky Pennington, Ash Bullement, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2016
Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in SwedenSixten Borg, Hareth Nahi, Markus Hansson, et al.
International Journal of Technology Assessment in Health Care|July 23, 2019
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic ReviewGemma Elizabeth Shields, Deborah Buck, Jamie Elvidge, et al.
International Journal of Technology Assessment in Health Care|April 24, 2023
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendationsJamie Elvidge, Ashley Summerfield, Saskia Knies, et al.
Journal of Affective Disorders|February 18, 2019
Risk assessment scales to predict risk of hospital treated repeat self-harm: A cost-effectiveness modelling analysisLeah Quinlivan, Sarah Steeg, Jamie Elvidge, et al.
Frontiers in Pharmacology|January 29, 2024
Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshopRavinder Claire, Jamie Elvidge, Shahid Hanif, et al.
Pharmacoeconomics|January 18, 2023
Living Health Technology Assessment: Issues, Challenges and OpportunitiesPraveen Thokala, Tushar Srivastava, Robert Smith, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 2, 2024
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in EuropeTuba Saygın Avşar, Jamie Elvidge, Claire Hawksworth, et al.
International Journal of Technology Assessment in Health Care|January 28, 2026
Innovating HTA: a call for capacity building and standardizationDiana M J Delnoij, Dalia M Dawoud, Jamie Elvidge, et al.
Journal of Comparative Effectiveness Research|June 21, 2022
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriersMaria Kamusheva, Bertalan Németh, Antal Zemplényi, et al.
Pageof 3